Antioxidant supplements for superficial siderosis symptoms
Part of Brain & nervous system clinical trials.
This study tests whether taking antioxidant supplements can help with symptoms like hearing loss, balance, or memory problems caused by superficial siderosis. It compares two different antioxidants to see if they slow down the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of superficial siderosis of the central nervous system.
- You must have at least one symptom like hearing loss, balance problems, or memory/cognitive issues.
- You must be able to swallow large capsules safely.
- You must not have a history of heart attack, stroke, or severe chronic lung disease.
- You must not have gout or a history of kidney stones (for the inosine arm).
- You must not be pregnant or breastfeeding, and must avoid other treatment studies for 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of two supplements, febuxostat and inosine, can help people with Parkinson's disease. It aims to see if this treatment is safe and may improve symptoms.
This trial compares two types of iron supplements (Sucrosomial Iron and Ferric Maltol) to see which works better and causes fewer side effects in women with low iron levels. It may help if you have mild to moderate anemia and are not taking other iron supplements.
This study tests an experimental drug (IMSB301) for people with rare genetic conditions that cause too much type 1 interferon activity (a part of the immune system). The goal is to see if the drug is safe and can help reduce symptoms.
This study tests whether an antioxidant supplement can improve blood vessel health in healthy adults. It compares the supplement's effects in non-Hispanic Black and non-Hispanic White participants to see if there are differences in how blood vessels respond.
This trial studies whether iguratimod improves symptoms in people with primary Sjögren’s syndrome, and checks how safe it is. It focuses on people with confirmed disease markers (anti-SSA/Ro-60) and ongoing dry eyes and dry mouth.
This pilot study tests a medicine called sodium thiosulfate (given as a skin shot) to treat abnormal calcium or bone formation in places they don’t belong. It’s meant for people whose condition is causing significant problems, and who are not planning surgery for the next year.
Hear when a new Superficial Siderosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.